16.02
+0.2(+1.26%)
Currency In USD
| Previous Close | 15.82 |
| Open | 15.96 |
| Day High | 16.27 |
| Day Low | 15.83 |
| 52-Week High | 23 |
| 52-Week Low | 11.09 |
| Volume | 142,603 |
| Average Volume | 306,633 |
| Market Cap | 429.62M |
| PE | -61.62 |
| EPS | -0.26 |
| Moving Average 50 Days | 17.39 |
| Moving Average 200 Days | 16.46 |
| Change | 0.2 |
If you invested $1000 in Eton Pharmaceuticals, Inc. (ETON) since IPO date, it would be worth $2,563.2 as of December 19, 2025 at a share price of $16.02. Whereas If you bought $1000 worth of Eton Pharmaceuticals, Inc. (ETON) shares 5 years ago, it would be worth $1,820.45 as of December 19, 2025 at a share price of $16.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
GlobeNewswire Inc.
Nov 24, 2025 9:30 PM GMT
DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
GlobeNewswire Inc.
Nov 12, 2025 9:30 PM GMT
DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
GlobeNewswire Inc.
Oct 23, 2025 8:30 PM GMT
DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that